"Stomach Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the STOMACH.
| Descriptor ID |
D013274
|
| MeSH Number(s) |
C04.588.274.476.767 C06.301.371.767 C06.405.249.767 C06.405.748.789
|
| Concept/Terms |
Stomach Neoplasms- Stomach Neoplasms
- Neoplasm, Stomach
- Stomach Neoplasm
- Neoplasms, Stomach
- Gastric Neoplasms
- Gastric Neoplasm
- Neoplasm, Gastric
- Neoplasms, Gastric
Cancer of Stomach- Cancer of Stomach
- Stomach Cancers
- Gastric Cancer
- Cancer, Gastric
- Cancers, Gastric
- Gastric Cancers
- Stomach Cancer
- Cancer, Stomach
- Cancers, Stomach
- Cancer of the Stomach
|
Below are MeSH descriptors whose meaning is more general than "Stomach Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Stomach Neoplasms".
This graph shows the total number of publications written about "Stomach Neoplasms" by people in this website by year, and whether "Stomach Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 2 | 2 |
| 1997 | 3 | 0 | 3 |
| 1998 | 1 | 0 | 1 |
| 2000 | 1 | 0 | 1 |
| 2001 | 1 | 0 | 1 |
| 2002 | 1 | 2 | 3 |
| 2003 | 3 | 0 | 3 |
| 2004 | 7 | 1 | 8 |
| 2005 | 2 | 1 | 3 |
| 2006 | 5 | 1 | 6 |
| 2007 | 2 | 0 | 2 |
| 2008 | 8 | 0 | 8 |
| 2009 | 2 | 1 | 3 |
| 2010 | 6 | 1 | 7 |
| 2011 | 8 | 1 | 9 |
| 2012 | 6 | 1 | 7 |
| 2013 | 8 | 0 | 8 |
| 2014 | 7 | 0 | 7 |
| 2015 | 6 | 0 | 6 |
| 2016 | 6 | 1 | 7 |
| 2017 | 11 | 1 | 12 |
| 2018 | 5 | 1 | 6 |
| 2019 | 9 | 2 | 11 |
| 2020 | 10 | 3 | 13 |
| 2021 | 9 | 0 | 9 |
| 2022 | 7 | 0 | 7 |
| 2023 | 8 | 0 | 8 |
| 2024 | 10 | 2 | 12 |
| 2025 | 13 | 0 | 13 |
| 2026 | 6 | 0 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "Stomach Neoplasms" by people in Profiles.
-
Krenning score enhances integrated biomarker models for survival prediction in PRRT-treated GEP-NET: a retrospective cohort study. Cancer Imaging. 2026 Aug 25; 26(1).
-
Claudin18.2 and the PD-1/PD-L1 axis in gastric cancer: mechanistic insights and implications for combination immunotherapy. J Transl Med. 2026 06 26; 24(1).
-
Morphologic Fault Lines in Distinguishing Gastric Cancer pTis From pT1a in Endoscopic Submucosal Dissection Specimens: An Interobserver Study. Pathol Int. 2026 Jun; 76(6):e70132.
-
The Genetics and Screening of Gastroenteropancreatic Neuroendocrine Tumors and Adrenal Tumors. Surg Clin North Am. 2026 Aug; 106(4):555-569.
-
Maintenance capecitabine after first-line platinum-based chemotherapy in advanced oesophagogastric adenocarcinoma: final analysis from the PLATFORM trial. Br J Cancer. 2026 Jul; 135(2):240-247.
-
Real World Outcomes With Chemotherapy and Immunotherapy in Metastatic Poorly Differentiated Gastroenteropancreatic Neuroendocrine Carcinomas. Cancer Med. 2026 Apr; 15(4):e71809.
-
Research priorities for cancers of the oesophagus and stomach: recommendations from a UK and Ireland patient and healthcare professional partnership exercise. Gut. 2025 11 10; 74(12):1949-1961.
-
Evaluating the role of postoperative long-acting somatostatin analog therapy in patients with metastatic neuroendocrine tumors undergoing surgical debulking. Surgery. 2026 Jan; 189:109762.
-
DNA-hypermethylated human gastric cancer circumvents apoptosis in the absence of TP53 mutation. J Pathol. 2025 Dec; 267(4):435-449.
-
A tumor microenvironment-based classification of gastric cancer for more effective diagnosis and treatment. Surg Oncol. 2025 Dec; 63:102298.